In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
about
Current concepts in the pathophysiology and treatment of aplastic anemiaMissing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in ChildhoodKinetic Analysis by Real-Time PCR of Hepatitis C Virus (HCV)-Specific T Cells in Peripheral Blood and Liver after Challenge with HCVHematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic AnemiaClonal hematopoiesis in acquired aplastic anemiaThe complex pathophysiology of acquired aplastic anaemiaEltrombopag in aplastic anemiaAnimal models for acquired bone marrow failure syndromes.Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia.Th17 immune responses contribute to the pathophysiology of aplastic anemia.STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.Recent advances in treatment of aplastic anemia.Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemiaCD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing.Aplastica anemia and viral hepatitisIFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation.GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.Predicting response to immunosuppressive therapy in childhood aplastic anemia.Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection.MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failureImmunologic aspects of hypoplastic myelodysplastic syndrome.Biology of BM failure syndromes: role of microenvironment and niches.T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndromeOligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia.Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemiaMemory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.Telomere maintenance and human bone marrow failureT-large granular lymphocyte leukemia: current molecular concepts.An update on the management of severe idiopathic aplastic anaemia in children.Anemia of Central Origin.Clonal predominance of CD8(+) T cells in patients with unexplained neutropeniaMyelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention.Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning.Acquired aplastic anemia in children.Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in miceImmunological derangement in hypocellular myelodysplastic syndromes.Induction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic target.
P2860
Q24685812-36A95AB9-7A67-4719-8C97-85DF8332AC48Q26798389-B6B265C1-2CB0-409E-A479-02ACE865D099Q27487122-73932DD0-8D7A-41F8-8061-BE66500F1028Q28071495-B65C636F-0C83-42E8-AF32-6B0128486264Q28079733-20210E62-7A63-479D-B704-6F673F0ECF0CQ28082135-31434C42-5E0C-4754-80FF-7A3836A82034Q28085299-72A542BD-B700-480C-B17E-6530F76948CBQ33367200-50171C14-D9A3-4E2C-B968-2F7F921A2FCAQ33820120-C8EBAB14-1E25-4386-9E06-21F9E60DC232Q34108996-FB7A09D0-2B38-45E4-9FF1-0B51F63E1477Q34360341-EFE5B81A-5BB7-4007-9C36-F51972FAB866Q34362636-8FDECF8F-84D3-4178-A150-6B6F57C5595BQ34451351-5A23FF0F-EAAE-4C21-8333-E5D4C9D74B01Q34482699-B597C45C-83FF-4CD9-B2C9-CD3EA1BA4803Q34520675-DBEC5FB1-589C-4AB3-A955-ACB85180C08BQ34549277-1A49D7EB-D8FC-4A7C-AD9D-DF2D124814C9Q34683972-AE32E258-6EF2-44BA-B8EC-61B910F12D46Q34802461-18E4E245-29B8-4421-81CB-95E017574D52Q34890595-02D913C4-BBE9-4921-8326-8E9CB86EDFA4Q34980349-6CCDE0F8-0607-4FA1-9D9D-C3611A8AE2DEQ35129815-9F16EA9B-C70A-421A-9E6E-4B39D85179BFQ35275808-ED081CA5-3236-4C4C-B52B-77884EE3F881Q35568527-B882C872-B80F-4435-8323-0F83AC42AAB2Q35848328-3A05ACBE-632F-4A65-84BB-1987CE991749Q35849198-4FAAE657-E93A-43D0-B27C-943CA23D503EQ35941563-362F59AF-78F7-4C69-89C6-CF271761B462Q36009002-CEB2211F-FAFD-4EA5-B3FF-A50A66CB4AE6Q36535499-CFDB9C1E-4910-4A76-9CE0-BAB77B19DD49Q36553599-8150065A-45A9-401A-924F-62F9B12F6291Q36591289-6876715E-7C94-4043-A6C1-9B48F0C6F9FDQ36687986-14226081-DE42-4582-88BB-FA597DD4DFC1Q36703904-82BE6227-3FAD-40B9-AB81-FD07B3FADD7BQ36784115-72C361C8-EAD4-4FF7-A4A7-64891C73874EQ37098105-A25BB092-A897-499A-B8FA-B82B271DC7C8Q37229440-FB92E7F7-30F5-4E72-B94D-E7D43780C66BQ37395170-B312F8BB-5A14-413D-A9C9-2A7B8D8B55D4Q37490754-236CEAF1-40CB-4040-A4B6-A7967F4AF26DQ37618824-3EC705B3-BBD0-49A8-ABC8-AC1FC248E2B6Q37724605-022ED4AD-86A1-438F-8D1E-12B1CFA3EDA3Q37766241-1026CF9F-3BA6-4572-B49A-4B56C131D92F
P2860
In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
In-vivo dominant immune respon ...... s by TCR beta-CDR3 sequencing.
@en
In-vivo dominant immune respon ...... s by TCR beta-CDR3 sequencing.
@nl
type
label
In-vivo dominant immune respon ...... s by TCR beta-CDR3 sequencing.
@en
In-vivo dominant immune respon ...... s by TCR beta-CDR3 sequencing.
@nl
prefLabel
In-vivo dominant immune respon ...... s by TCR beta-CDR3 sequencing.
@en
In-vivo dominant immune respon ...... s by TCR beta-CDR3 sequencing.
@nl
P2093
P1433
P1476
In-vivo dominant immune respon ...... s by TCR beta-CDR3 sequencing.
@en
P2093
Antonio M Risitano
Jaroslaw P Maciejewski
Magdalena Plasilova
Neal S Young
Spencer Green
Weihua Zeng
P304
P356
10.1016/S0140-6736(04)16724-X
P407
P577
2004-07-01T00:00:00Z